Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915499 · ClinicalTrials.gov registry record · NA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
A NA study, sponsored by ResMed.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00915499 is a NA study that has completed, run by ResMed. The registered enrollment target is 66 participants.
The verdict
NCT00915499, a NA study, has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether adaptive servo-ventilation (ASV) or continuous positive airway pressure (CPAP) is better at treating complex sleep apnea over time.
Interventions
- DEVICE VPAP Adapt SV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00915499
The ClinicalTrials.gov registry entry for NCT00915499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VPAP Adapt SV is the first listed.
NCT00915499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00915499 about?
NCT00915499 is a clinical study titled "Complex Sleep Apnea Syndrome (CompSAS) Resolution Study". The purpose of this study is to determine whether adaptive servo-ventilation (ASV) or continuous positive airway pressure (CPAP) is better at treating complex sleep apnea over time.
What is the current status of trial NCT00915499?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2009-05. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00915499?
The interventions under investigation include: VPAP Adapt SV (DEVICE).
Who is sponsoring clinical trial NCT00915499?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.